Kekoa Taparra, MD, PhD, MPH

UCLA Health

Los Angeles, CA

Disclosures:

Employment: none
Compensation: none
Ownership: none
Leadership: none

Presentations

Sep 29

3388 - A Phase II Trial In Progress: Alpha-emitting radioNucliDe or Beta-Emitting RadiOnuclide Combined With MEtastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)<sup></sup>

02:15pm - 03:30pm ET